Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia
MJ Groves, M Sales, L Baker, Michael Griffiths, N Pratt, S Tauro
Research output: Contribution to journal › Article
19Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia'. Together they form a unique fingerprint.